151 related articles for article (PubMed ID: 15528840)
1. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
Nakayama H; Yamakuni H; Nakayama A; Maeda Y; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2004 Nov; 96(3):301-6. PubMed ID: 15528840
[TBL] [Abstract][Full Text] [Related]
2. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
Gonsalves S; Watson J; Ashton C
Eur J Pharmacol; 1996 Jun; 305(1-3):181-5. PubMed ID: 8813551
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
4. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
[TBL] [Abstract][Full Text] [Related]
5. The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
Watson JW; Gonsalves SF; Fossa AA; McLean S; Seeger T; Obach S; Andrews PL
Br J Pharmacol; 1995 May; 115(1):84-94. PubMed ID: 7544198
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets.
Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W
Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats.
Takeda N; Hasegawa S; Morita M; Horii A; Uno A; Yamatodani A; Matsunaga T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):647-52. PubMed ID: 9053584
[TBL] [Abstract][Full Text] [Related]
8. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
9. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
10. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
11. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
[TBL] [Abstract][Full Text] [Related]
12. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
[TBL] [Abstract][Full Text] [Related]
13. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
Kamato T; Miyata K; Ito H; Yuki H; Yamano M; Honda K
Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
[TBL] [Abstract][Full Text] [Related]
14. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
[TBL] [Abstract][Full Text] [Related]
15. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
[TBL] [Abstract][Full Text] [Related]
16. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
17. Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets.
Bountra C; Bunce K; Dale T; Gardner C; Jordan C; Twissell D; Ward P
Eur J Pharmacol; 1993 Nov; 249(1):R3-4. PubMed ID: 7506663
[TBL] [Abstract][Full Text] [Related]
18. Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats.
Takeda N; Hasegawa S; Morita M; Horii A; Uno A; Yamatodani A; Matsunaga T
Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):589-90. PubMed ID: 8786672
[TBL] [Abstract][Full Text] [Related]
19. The effects of different antiemetic agents on morphine-induced emesis in ferrets.
Wynn RL; Essien E; Thut PD
Eur J Pharmacol; 1993 Sep; 241(1):47-54. PubMed ID: 8223924
[TBL] [Abstract][Full Text] [Related]
20. Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties.
Angel I; Schoemaker H; Prouteau M; Garreau M; Langer SZ
Eur J Pharmacol; 1993 Mar; 232(2-3):139-45. PubMed ID: 8385615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
